HK1039113A1 - Benzothieno Ä3,2-CÜpyridines as alpha2 antagonists - Google Patents
Benzothieno Ä3,2-CÜpyridines as alpha2 antagonistsInfo
- Publication number
- HK1039113A1 HK1039113A1 HK01108819A HK01108819A HK1039113A1 HK 1039113 A1 HK1039113 A1 HK 1039113A1 HK 01108819 A HK01108819 A HK 01108819A HK 01108819 A HK01108819 A HK 01108819A HK 1039113 A1 HK1039113 A1 HK 1039113A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cüpyridines
- benzothieno
- alpha2 antagonists
- alpha2
- antagonists
- Prior art date
Links
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98203363 | 1998-10-06 | ||
PCT/EP1999/007418 WO2000020422A1 (en) | 1998-10-06 | 1999-10-01 | BENZOTHIENO[3,2-c]PYRIDINES AS α2 ANTAGONISTS |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1039113A1 true HK1039113A1 (en) | 2002-04-12 |
Family
ID=8234188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01108819A HK1039113A1 (en) | 1998-10-06 | 2001-12-15 | Benzothieno Ä3,2-CÜpyridines as alpha2 antagonists |
Country Status (28)
Country | Link |
---|---|
US (2) | US6426350B1 (xx) |
EP (1) | EP1117667B1 (xx) |
JP (1) | JP4580555B2 (xx) |
KR (1) | KR20010071828A (xx) |
CN (1) | CN1158287C (xx) |
AR (1) | AR023678A1 (xx) |
AT (1) | ATE363485T1 (xx) |
AU (1) | AU760226B2 (xx) |
BG (1) | BG64625B1 (xx) |
BR (1) | BR9913110A (xx) |
CA (1) | CA2346084C (xx) |
CZ (1) | CZ20011103A3 (xx) |
DE (1) | DE69936219T2 (xx) |
EE (1) | EE04835B1 (xx) |
ES (1) | ES2288025T3 (xx) |
HK (1) | HK1039113A1 (xx) |
HU (1) | HUP0103612A3 (xx) |
ID (1) | ID28280A (xx) |
IL (2) | IL142442A0 (xx) |
NO (1) | NO20011309D0 (xx) |
NZ (1) | NZ509911A (xx) |
PL (1) | PL347184A1 (xx) |
RU (1) | RU2222542C2 (xx) |
SK (1) | SK4312001A3 (xx) |
TR (1) | TR200100954T2 (xx) |
TW (1) | TWI251595B (xx) |
UA (1) | UA70334C2 (xx) |
WO (1) | WO2000020422A1 (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2305284A3 (en) * | 2002-03-08 | 2012-11-14 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Use of EGFR transactivation inhibitors in human cancer |
JP2005521728A (ja) * | 2002-04-03 | 2005-07-21 | オリオン コーポレーション | CNS関連疾患のためのα2−アドレナリン受容体アンタゴニストの使用 |
CN1972938B (zh) | 2004-04-12 | 2010-09-29 | 大正制药株式会社 | 环状胺化合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3752820A (en) * | 1972-03-20 | 1973-08-14 | Colgate Palmolive Co | Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives |
FR2570701B1 (fr) * | 1984-09-27 | 1987-05-22 | Synthelabo | Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique |
US4686226A (en) * | 1985-09-03 | 1987-08-11 | Merck & Co., Inc. | Substituted benzo[b]furo- and benzo[b]thieno quinolizines |
EP0339959A3 (en) * | 1988-04-27 | 1991-03-20 | Glaxo Group Limited | Lactam derivatives |
US5100891A (en) * | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
DE69531476T2 (de) * | 1994-09-12 | 2004-06-09 | Lilly Industries Ltd., Basingstoke | Serotonergische Modulatoren |
JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
UA52681C2 (uk) | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі |
-
1999
- 1999-01-10 UA UA2001031998A patent/UA70334C2/uk unknown
- 1999-10-01 EE EEP200100206A patent/EE04835B1/xx not_active IP Right Cessation
- 1999-10-01 IL IL14244299A patent/IL142442A0/xx active IP Right Grant
- 1999-10-01 DE DE69936219T patent/DE69936219T2/de not_active Expired - Lifetime
- 1999-10-01 PL PL99347184A patent/PL347184A1/xx not_active Application Discontinuation
- 1999-10-01 JP JP2000574534A patent/JP4580555B2/ja not_active Expired - Fee Related
- 1999-10-01 WO PCT/EP1999/007418 patent/WO2000020422A1/en active IP Right Grant
- 1999-10-01 ID IDW20010781A patent/ID28280A/id unknown
- 1999-10-01 US US09/806,432 patent/US6426350B1/en not_active Expired - Lifetime
- 1999-10-01 CA CA2346084A patent/CA2346084C/en not_active Expired - Fee Related
- 1999-10-01 ES ES99947469T patent/ES2288025T3/es not_active Expired - Lifetime
- 1999-10-01 CN CNB998116777A patent/CN1158287C/zh not_active Expired - Fee Related
- 1999-10-01 TW TW088116899A patent/TWI251595B/zh not_active IP Right Cessation
- 1999-10-01 KR KR1020017000400A patent/KR20010071828A/ko active Search and Examination
- 1999-10-01 TR TR2001/00954T patent/TR200100954T2/xx unknown
- 1999-10-01 RU RU2001111753/04A patent/RU2222542C2/ru not_active IP Right Cessation
- 1999-10-01 NZ NZ509911A patent/NZ509911A/xx unknown
- 1999-10-01 SK SK431-2001A patent/SK4312001A3/sk unknown
- 1999-10-01 AT AT99947469T patent/ATE363485T1/de not_active IP Right Cessation
- 1999-10-01 HU HU0103612A patent/HUP0103612A3/hu unknown
- 1999-10-01 BR BR9913110-2A patent/BR9913110A/pt not_active Application Discontinuation
- 1999-10-01 AU AU60899/99A patent/AU760226B2/en not_active Ceased
- 1999-10-01 CZ CZ20011103A patent/CZ20011103A3/cs unknown
- 1999-10-01 EP EP99947469A patent/EP1117667B1/en not_active Expired - Lifetime
- 1999-10-05 AR ARP990105039A patent/AR023678A1/es active IP Right Grant
-
2001
- 2001-03-12 BG BG105331A patent/BG64625B1/bg unknown
- 2001-03-15 NO NO20011309A patent/NO20011309D0/no not_active Application Discontinuation
- 2001-04-04 IL IL142442A patent/IL142442A/en not_active IP Right Cessation
- 2001-12-15 HK HK01108819A patent/HK1039113A1/xx not_active IP Right Cessation
-
2002
- 2002-04-16 US US10/123,338 patent/US6774129B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL140197A0 (en) | β-CARBOLINE COMPOUNDS | |
EG24743A (en) | Heterocyclic compounds. | |
ZA200203581B (en) | Bicyclic imidazo-3-yl-amine derivatives. | |
HUP0203375A3 (en) | Substituted oxoazaheterocyclyl compounds | |
HRP20020102B1 (en) | Novel spiro compounds | |
ZA200108968B (en) | New compounds. | |
HUP0101753A3 (en) | Boring-tool | |
GB9826359D0 (en) | Novel receptors | |
EG24605A (en) | Antihistaminic spiro compounds | |
ZA200110021B (en) | Substituted imidazothiazoles as antidepressant agents. | |
IL137329A0 (en) | Vla-4 antagonists | |
EG22286A (en) | Fungicidal combinations comprising thieno ä2,3-dü pyrimidin-4-one | |
EP1210978A4 (en) | PIPETTES DEVICE | |
EP0986553A4 (en) | DIHYDROPYRIMIDONE DERIVATIVES AS NPY ANTAGONISTS | |
PL353372A1 (en) | Substituted heterocyclyl-2h-chromenes | |
HK1039113A1 (en) | Benzothieno Ä3,2-CÜpyridines as alpha2 antagonists | |
GB9911456D0 (en) | Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives | |
PL352101A1 (en) | Substituted phenylcyclohexanocarboxyamides | |
ZA99171B (en) | Piperazino derivatives as neurokinin antagonists. | |
ZA200108302B (en) | Substituted bicyclic heteroaryl compounds as integrin antagonists. | |
GB9918623D0 (en) | Lathe | |
PL343921A1 (en) | Toolhead | |
ZA200203582B (en) | Bicyclic imidazo-5-yl-amine derivatives. | |
TW401868U (en) | Improved drill | |
ZA200200734B (en) | Spiro compounds. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20101001 |